Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FATE | AVIR | INZY | ||
| Company | Fate Therapeutics | Atea Pharmaceuticals Inc | Inozyme Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.42 | 3.28 | 4.34 | ||
| High | 2.48 | 3.31 | 4.42 | ||
| Low | 2.32 | 3.25 | 4.21 | ||
| Last | 2.43 | 3.29 | 4.36 | ||
| Change | +0.06 | +0.05 | +0.07 | ||
| % Change | +2.53% | +1.54% | +1.63% | ||
| Volume | 1,812,100 | 78,500 | 261,900 | ||
| 20-Day Average Volume | 1,321,645 | 132,090 | 233,600 | ||
| Previous Close | 2.37 | 3.24 | 4.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.93 | 3.47 | 4.99 | ||
| 20-Day Raw Stochastic | 15.24% | 10.94% | 10.87% | ||
| 20-Day Relative Strength | 34.23% | 42.42% | 36.43% | ||
| Weighted Alpha | -41.63 | -6.45 | +2.09 | ||
| Today's Opinion | 100% Sell | 88% Sell | 56% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 56% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Sell | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.30% since 10/25/24 | -1.79% since 10/25/24 | -8.98% since 10/25/24 | ||
| Low | 2.27 on 10/31/24 | 3.22 on 10/31/24 | 4.21 on 11/01/24 | ||
| High | 2.88 on 10/29/24 | 3.48 on 10/28/24 | 4.90 on 10/28/24 | ||
| 1-Month | |||||
| %Chg | -27.46% since 10/01/24 | -1.20% since 10/01/24 | -13.15% since 10/01/24 | ||
| Low | 2.27 on 10/31/24 | 3.22 on 10/31/24 | 4.21 on 11/01/24 | ||
| High | 3.35 on 10/04/24 | 3.86 on 10/21/24 | 5.59 on 10/21/24 | ||
| 3-Month | |||||
| %Chg | -50.20% since 08/01/24 | -9.37% since 08/01/24 | -19.41% since 08/01/24 | ||
| Low | 2.27 on 10/31/24 | 3.20 on 08/06/24 | 4.21 on 11/01/24 | ||
| High | 4.66 on 08/02/24 | 4.14 on 09/17/24 | 6.24 on 09/17/24 | ||
| 6-Month | |||||
| %Chg | -40.59% since 05/01/24 | -14.55% since 05/01/24 | -5.42% since 05/01/24 | ||
| Low | 2.27 on 10/31/24 | 3.14 on 07/10/24 | 4.21 on 11/01/24 | ||
| High | 5.92 on 07/26/24 | 4.14 on 09/17/24 | 6.24 on 09/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 276,724 | 277,748 | 273,520 | ||
| Shares Outstanding, K | 113,878 | 84,422 | 62,734 | ||
| Annual Sales | 63,530,000 | 0 | 0 | ||
| Annual Net Income | -160,930,000 | -135,960,000 | -71,170,000 | ||
| Last Quarter Sales | 6,770,000 | 0 | 0 | ||
| Last Quarter Net Income | -38,430,000 | -40,520,000 | -27,030,000 | ||
| 60-Month Beta | 1.88 | 0.17 | 1.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 08/13/24 | -0.48 on 08/07/24 | -0.44 on 08/06/24 | ||
| Latest Earnings Date | 11/13/24 | 11/07/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||